ask="0.7400"
ask_size="200"
average_daily_volume="132384"
bid="N/A"
bid_size="N/A"
book_value="0.7250"
change="-0.0294"
change_from_200_day_moving_average="-0.7024"
change_from_50_day_moving_average="-0.4904"
change_from_52_week_high="-1.3545"
change_From_52_week_low="0.0155"
change_in_percent="-4.3562%"
close="0.6455"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.6788"
high_52_weeks="2.0000"
last_trade_date="2/23/2017"
last_trade_price="0.6455"
last_trade_size="821"
last_trade_time="4:00pm"
low="0.6300"
low_52_weeks="0.6300"
market_capitalization="24.95M"
moving_average_200_day="1.3479"
moving_average_50_day="1.1359"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.6600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-52.1107%"
percent_change_from_50_day_moving_average="-43.1718%"
percent_change_from_52_week_high="-67.7250%"
percent_change_from_52_week_low="+2.4603%"
previous_close="0.6749"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.9309"
price_per_sales="2.6617"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.3700"
stock_exchange="NMS"
symbol="AVIR"
volume="117860"
weeks_range_52="0.6300 - 2.0000"
